Estimating a preference-based index for a menopause specific health quality of life questionnaire

被引:34
作者
Brazier J.E. [1 ]
Roberts J. [1 ]
Platts M. [2 ]
Zoellner Y.F. [3 ]
机构
[1] Health Economics/Decision Science, School of Health/Related Research, The University of Sheffield, Sheffield S1 4DA, Regent Court
[2] Inst. of Gen. Practice/Primary Care, School of Health/Related Research, The University of Sheffield, Sheffield, Community Sciences Building
[3] Global Health Economics, Solvay Pharmaceuticals, D-30002 Hannover
关键词
Menopausal Symptom; Full Health; Vaginal Dryness; Main Effect Model; Health State Utility;
D O I
10.1186/1477-7525-3-13
中图分类号
学科分类号
摘要
Background: The aim of the study was to develop a menopause-specific, preference-based healthrelated quality-of-life (HRQoL) index reflecting both menopausal symptoms and potential side-effects of Hormone Replacement Therapy (HRT). Methods: The study had three phases: the development of a health state classification, a prospective valuation survey and the estimation of a model to interpolate HRQoL indices for all remaining health states as defined by the classification. A menopausal health state classification was developed with seven dimensions: hot flushes, aching joints/muscles, anxious/frightened feelings, breast tenderness, bleeding, vaginal dryness and undesirable androgenic signs. Each dimension contains between three and five levels and defines a total of 6,075 health states. A sample of 96 health states was selected for the valuation survey. These states were valued by a sample of 229 women aged 45 to 60, randomly selected from 6 general practice lists in Sheffield, UK. Respondents were asked to complete a time trade-off (TTO) task for nine health states, resulting in an average of 16.5 values for each health state. Results: Mean health states valued range from 0.48 to 0.98 (where 1.0 is full health and zero is for states regarded as equivalent to death). Symptoms, as described by the classification system, can be rank-ordered in terms of their impact (from high to low) on menopausal HRQoL as follows: aching joints and muscles, bleeding, breast tenderness, anxious or frightened feelings, vaginal dryness, androgenic signs. Hot flushes did not significantly contribute to model fit. The preferred model produced a mean absolute error of 0.053, but suffered from bias at both ends of the scale. Conclusion: This article presents an attempt to directly value a condition specific health state classification. The overall fit was disappointing, but the results demonstrate that menopausal symptoms are perceived by patients to have a significant impact on utility. The overall effect is modest compared to the more generic health state descriptions such as the EQ-5D. The resultant algorithm generates a preference-based index that can be used economic evaluation and that reflects the impact of this condition. © 2005 Brazier et al; licensee BioMed Central Ltd.
引用
收藏
页数:9
相关论文
共 23 条
[1]  
NICE Guide to the Methods of Technology Appraisal, (2004)
[2]  
Guidelines for the Pharmaceutical Industry on the Submission to the Pharmaceutical Benefits Advisory Committee, (1992)
[3]  
Ontario Guidelines for the Economic Evaluation of Pharmaceutical Products, (1994)
[4]  
Brazier J., Deverill M., Green C., Harper R., Booth A., A review of the use of health status measures in economic evaluation, Health Technol. Assess., 3, 1-4, pp. 1-164, (1999)
[5]  
Tosteson A.N.A., Gabriel S.E., Kneeland T.S., Moncur M.M., Manganiello P.D., Schiff I., Ettinger B., Melton L.J., Has the impact of hormone replacement therapy on health-related quality of life been undervalued?, J. Womens Health Gend Based Med., 9, pp. 110-130, (2000)
[6]  
Zoellner Y.F., Oliver P., Brazier J.E., Alt J., Schaefer M., Reliability and validity of a newly developed menopause-specific quality-of-life questionnaire, the QualiPause Inventory (QPI), Qual. Life Res., 10, (2001)
[7]  
Brazier J.E., Kolotkin R.L., Crosby R.D., Williams G.R., Estimating a preference-based index from the Impact of Weight on Quality of Life Instrument (IWQOL-Lite) from the SF-6D, Value Health, 7, pp. 490-498, (2004)
[8]  
Tsuchyia A., Brazier J., McColl E., Parkin D., Deriving preference-based condition-specific instruments: Converting AQLQ into EQ-5D indices, (2002)
[9]  
Dixon S., McEwan P., Currie C.J., Estimating the health utility of treatment in adults with growth hormone deficiency, J. Outcomes Res., 7, pp. 1-12, (2003)
[10]  
Brazier J.E., Dixon S., Condition specific measures in economic appraisal, Health Econ., 4, pp. 255-264, (1995)